Mass spectrometry for clinical bioanalysis without chromatographic separation: bioequivalence for bupropion and its metabolites

The results of this study indicate that the HT-SPE-MS/MS system shows potential for high-throughput in vivo bioanalysis, particularly in bioavailability and bioequivalence studies.

Authors

Institutions

Publication Details

Journal
Bioanalysis
Published
2025-09-05
DOI
https://doi.org/10.1080/17576180.2025.2557187
Primary Topic
Biosimilars and Bioanalytical Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mass spectrometry for clinical bioanalysis without chromatographic separation: bioequivalence for bupropion and its metabolites

Patrick J. Faustino, Jinhui Zhang
Bioanalysis
Biosimilars and Bioanalytical Methods
article

Mass spectrometry for clinical bioanalysis without chromatographic separation: bioequivalence for bupropion and its metabolites

Patrick J. Faustino, Jinhui Zhang
article en

Abstract

The results of this study indicate that the HT-SPE-MS/MS system shows potential for high-throughput in vivo bioanalysis, particularly in bioavailability and bioequivalence studies.

BioanalysisVol. 17(18)
Food and Drug Administration (TH)
Openalex Percentile: Top 75%
Biosimilars and Bioanalytical Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Mass spectrometry for clinical bioanalysis without chromatographic separation: bioequivalence for bupropion and its metabolites — Patrick J. Faustino, Jinhui Zhang · Bioanalysis (2025) | TGRS Research Map | TGRS